| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.03 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.56 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |